Details of the Drug

General Information of Drug (ID: DMJBIGK)

Drug Name

OpRegen

Synonyms

HESC-derived RPEs (AMD), Cell Cure/Hadasit/Hadassah; Human embryonic stem cell-derived retinal pigmented epithelial cells (age-related macular degeneration), Cell Cure/Hadasit/Hadassah

Indication

Disease Entry	ICD 11	Status	REF
Dry age-related macular degeneration	9B75	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Human embryonic stem (hES) cell-derived therapeutics

Cross-matching ID

TTD ID: D0J0XN

References

1	ClinicalTrials.gov (NCT02286089) Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration. U.S. National Institutes of Health.